# clm_FA96CB92CE64

subject: Gilead Sciences (/record/gilead-sciences.md)  
predicate: quarterly_operating_income  
value: 1,043,914,000 United States dollar  
valid_from: 2012-09-30  
valid_to: 2013-03-31  
published: 2012-11-06  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_4AB2B075DD45  
last_updated: 2026-11-08  
cite: AsOf. "Gilead Sciences quarterly operating income: 1,043,914,000 United States dollar", as of 2012-09-30 (until 2013-03-31). Claim clm_FA96CB92CE64, https://asof.is/claim/clm_FA96CB92CE64, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/882095/000088209512000029/0000882095-12-000029-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2012, filed 2012-11-06  

## Sources

- https://www.sec.gov/Archives/edgar/data/882095/000088209512000029/0000882095-12-000029-index.htm (primary, SEC EDGAR 10-Q Q3 FY2012, published 2012-11-06)

## Supersedes

- [Gilead Sciences](/record/gilead-sciences.md) | quarterly_operating_income | 1,059,092,000 United States dollar | valid 2012-06-30 to 2012-09-30 | conf 0.95 | superseded | superseded_by [clm_FA96CB92CE64](/claim/clm_FA96CB92CE64.md) | [clm_74B44D14A03E](/claim/clm_74B44D14A03E.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.